Table 4. Maximum corrected count ratio (MCCR) at the baseline and 1-month after therapy for group I (rheumatoid arthritis) and Group II (osteoarthritis) joints in responder and non-responder participants. Numbers represent the median (range).
| Phase | Group I Joints | Group II Joints | |||
|---|---|---|---|---|---|
| Responders | Non-responders | Responders | Non-responders | ||
| Soft-tissue phase | |||||
| Baseline | 1.31 (0.70–7.30) | 1.65 (0.55–2.95) | 1.37 (0.60–5.07) | 1.59 (0.71–3.67) | |
| One-month | 1.15 (0.60–4.70) | 1.10 (0.50–1.70) | 1.90 (1.10–3.20) | 1.10 (0.50–1.90) | |
| % Change | −28 (−61 to −131) | −33 (−70 to −118) | 18 (−52 to 188) | −36 (−63 to −144) | |
| Delayed osseous phase | |||||
| Baseline | 1.19 (0.49–3.91) | 1.25 (0.81–2.93) | 1.46 (0.62–6.42) | 1.42 (0.69–6.14) | |
| One-month | 1.00 (0.60–3.60) | 1.00 (0.50–2.80) | 1.20 (0.70–2.30) | 1.20 (0.60–4.50) | |
| % Change | 2 (−46 to −169) | −15 (−58 to −43) | −18 (−89 to −14) | −7 (−49 to −88) | |
MCCR, maximum corrected count ratio.